Down-regulation of K+ channels by human parvovirus B19 capsid protein VP1

Biochemical and Biophysical Research Communications

Volumn 450, Issue 4, 2014, Pages 1396-1401

  Ahmed, Musaab ^a   Almilaji, Ahmad ^a   Munoz, Carlos ^a   Elvira, Bernat ^a   Shumilina, Ekaterina ^a   Bock, C Thomas ^a   Kandolf, Reinhard ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Kv1.3; Kv1.5; Lysophosphatidylcholine; Phospholipase A2; Viral myocarditis

Indexed keywords

DACTINOMYCIN; LYSOPHOSPHATIDYLCHOLINE; POTASSIUM CHANNEL KV1.3; POTASSIUM CHANNEL KV1.5; PROTEIN VP1;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN PARVOVIRUS B19; MYOCARDITIS; NONHUMAN; OOCYTE; POTASSIUM CURRENT; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VOLTAGE CLAMP TECHNIQUE; XENOPUS;

MIRIDAE; PARVOVIRUS;

K(+) CHANNELS; KV1.3; KV1.5; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; VIRAL MYOCARDITIS;

ANIMALS; CAPSID PROTEINS; DOWN-REGULATION; HUMANS; PARVOVIRUS B19, HUMAN; POTASSIUM CHANNELS; XENOPUS;

EID: 84906091772     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.07.003     Document Type: Article

References (48)

1. E.D. Heegaard, and K.E. Brown Human parvovirus B19 Clin. Microbiol. Rev. 15 2002 485 505
2. K.E. Brown, N.S. Young, and J.M. Liu Molecular, cellular and clinical aspects of parvovirus B19 infection Crit. Rev. Oncol. Hematol. 16 1994 1 31
3. M.J. Anderson, S.E. Jones, S.P. Fisher-Hoch, E. Lewis, S.M. Hall, C.L. Bartlett, B.J. Cohen, P.P. Mortimer, and M.S. Pereira Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1 1983 1378
4. N.S. Young, and K.E. Brown Parvovirus B19 N. Engl. J. Med. 350 2004 586 597
5. W.C. Koch Fifth (human parvovirus) and sixth (herpesvirus 6) diseases Curr. Opin. Infect. Dis. 14 2001 343 356
6. H.W. Lehmann, A. Knoll, R.M. Kuster, and S. Modrow Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood Arthritis Rheum. 48 2003 1631 1638
7. D. Dingli, D.H. Pfizenmaier, E. Arromdee, P. Wennberg, P.C. Spittell, A. Chang-Miller, and B.L. Clarke Severe digital arterial occlusive disease and acute parvovirus B19 infection Lancet 356 2000 312 314
8. S. Trapani, M. Ermini, and F. Falcini Human parvovirus B19 infection: its relationship with systemic lupus erythematosus Semin. Arthritis Rheum. 28 1999 319 325
9. Y.V. Karetnyi, P.R. Beck, R.S. Markin, A.N. Langnas, and S.J. Naides Human parvovirus B19 infection in acute fulminant liver failure Arch. Virol. 144 1999 1713 1724
10. E.M. Sokal, M. Melchior, C. Cornu, A.T. Vandenbroucke, J.P. Buts, B.J. Cohen, and G. Burtonboy Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children Lancet 352 1998 1739 1741
11. L.C. Corman, and D.J. Dolson Polyarteritis nodosa and parvovirus B19 infection Lancet 339 1992 491
12. T.H. Finkel, T.J. Torok, P.J. Ferguson, E.L. Durigon, S.R. Zaki, D.Y. Leung, R.J. Harbeck, E.W. Gelfand, F.T. Saulsbury, and J.R. Hollister Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 343 1994 1255 1258
13. K.E. Brown, J.R. Hibbs, G. Gallinella, S.M. Anderson, E.D. Lehman, P. McCarthy, and N.S. Young Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen) N. Engl. J. Med. 330 1994 1192 1196
14. U. Kuhl, M. Pauschinger, T. Bock, K. Klingel, C.P. Schwimmbeck, B. Seeberg, L. Krautwurm, W. Poller, H.P. Schultheiss, and R. Kandolf Parvovirus B19 infection mimicking acute myocardial infarction Circulation 108 2003 945 950
15. C. Tschope, C.T. Bock, M. Kasner, M. Noutsias, D. Westermann, P.L. Schwimmbeck, M. Pauschinger, W.C. Poller, U. Kuhl, R. Kandolf, and H.P. Schultheiss High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction Circulation 111 2005 879 886
16. C.T. Bock, K. Klingel, and R. Kandolf Human parvovirus B19-Associated myocarditis N. Engl. J. Med. 362 2010 1248 1249
17. J. Crane Parvovirus B19 infection in pregnancy J. Obstet. Gynaecol. Can. 24 2002 727 743
18. C.E. Oyer, E.H. Ongcapin, J. Ni, N.E. Bowles, and J.A. Towbin Fatal intrauterine adenoviral endomyocarditis with aortic and pulmonary valve stenosis: diagnosis by polymerase chain reaction Hum. Pathol. 31 2000 1433 1435
19. A. Telerman, M. Tuynder, T. Dupressoir, B. Robaye, F. Sigaux, E. Shaulian, M. Oren, J. Rommelaere, and R. Amson A model for tumor suppression using H-1 parvovirus Proc. Natl. Acad. Sci. U.S.A. 90 1993 8702 8706
20. K.E. Brown, S.M. Anderson, and N.S. Young Erythrocyte P antigen: cellular receptor for B19 parvovirus Science 262 1993 114 117
21. Y. Munakata, T. Saito-Ito, K. Kumura-Ishii, J. Huang, T. Kodera, T. Ishii, Y. Hirabayashi, Y. Koyanagi, and T. Sasaki Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection Blood 2005
22. B.D. Bultmann, K. Klingel, K. Sotlar, C.T. Bock, H.A. Baba, M. Sauter, and R. Kandolf Fatal parvovirus B19-Associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease Hum. Pathol. 34 2003 92 95
23. K. Klingel, M. Sauter, C.T. Bock, G. Szalay, J.J. Schnorr, and R. Kandolf Molecular pathology of inflammatory cardiomyopathy Med. Microbiol. Immunol. (Berl) 193 2004 101 107
24. S.F. Cotmore, V.C. McKie, L.J. Anderson, C.R. Astell, and P. Tattersall Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments J. Virol. 60 1986 548 557
25. A. Gigler, S. Dorsch, A. Hemauer, C. Williams, S. Kim, N.S. Young, S. Zolla-Pazner, H. Wolf, M.K. Gorny, and S. Modrow Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins J. Virol. 73 1999 1974 1979
26. S. Canaan, Z. Zadori, F. Ghomashchi, J. Bollinger, M. Sadilek, M.E. Moreau, P. Tijssen, and M.H. Gelb Interfacial enzymology of parvovirus phospholipases A2 J. Biol. Chem. 279 2004 14502 14508
27. Z. Zadori, J. Szelei, M.C. Lacoste, Y. Li, S. Gariepy, P. Raymond, M. Allaire, I.R. Nabi, and P. Tijssen A viral phospholipase A2 is required for parvovirus infectivity Dev. Cell 1 2001 291 302
28. S. Dorsch, G. Liebisch, B. Kaufmann, P. von Landenberg, J.H. Hoffmann, W. Drobnik, and S. Modrow The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity J. Virol. 76 2002 2014 2018
29. A. Lupescu, C.T. Bock, P.A. Lang, S. Aberle, H. Kaiser, R. Kandolf, and F. Lang Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1 J. Virol. 80 2006 11370 11380
30. A. Almilaji, K. Szteyn, E. Fein, T. Pakladok, C. Munoz, B. Elvira, S.T. Towhid, I. Alesutan, E. Shumilina, C.T. Bock, R. Kandolf, and F. Lang Down-regulation of Na/K+ atpase activity by human parvovirus B19 capsid protein VP1 Cell. Physiol. Biochem. 31 2013 638 648
31. R.A. Rabini, P. Fumelli, G. Zolese, E. Amler, E. Salvolini, R. Staffolani, N. Cester, and L. Mazzanti Modifications induced by plasma from insulin-dependent diabetic patients and by lysophosphatidylcholine on human Na+, K(+)-Adenosine triphosphatase J. Clin. Endocrinol. Metab. 83 1998 2405 2410
32. A. Wickenden K(+) channels as therapeutic drug targets Pharmacol. Ther. 94 2002 157 182
33. A. Felipe, J. Bielanska, N. Comes, A. Vallejo, S. Roig, Y.C. Ramon, E. Condom, J. Hernandez-Losa, and J.C. Ferreres Targeting the voltage-dependent K(+) channels Kv1.3 and Kv1.5 as tumor biomarkers for cancer detection and prevention Curr. Med. Chem. 19 2012 661 674
34. C. Munoz, R.H. Tovolli, M. Sopjani, I. Alesutan, R.S. Lam, G. Seebohm, M. Foller, and F. Lang Activation of voltage gated K(+) channel Kv1.5 by beta-catenin Biochem. Biophys. Res. Commun. 417 2012 692 696
35. L. Tyan, M. Sopjani, M. Dermaku-Sopjani, E. Schmid, W. Yang, N.T. Xuan, E. Shumilina, and F. Lang Inhibition of voltage-gated K+ channels in dendritic cells by rapamycin Am. J. Physiol. Cell Physiol. 299 2010 C1379 1385
36. Z. Hosseinzadeh, L. Dong, S.K. Bhavsar, J. Warsi, A. Almilaji, and F. Lang Upregulation of peptide transporters PEPT1 and PEPT2 by Janus kinase JAK2 Cell. Physiol. Biochem. 31 2013 673 682
37. M. Shojaiefard, Z. Hosseinzadeh, T. Pakladok, S.K. Bhavsar, and F. Lang Stimulation of Na(+) coupled phosphate transporter NaPiIIa by janus kinase JAK2 Biochem. Biophys. Res. Commun. 431 2013 186 191
38. U. Henrion, S. Zumhagen, K. Steinke, N. Strutz-Seebohm, B. Stallmeyer, F. Lang, E. Schulze-Bahr, and G. Seebohm Overlapping cardiac phenotype associated with a familial mutation in the voltage sensor of the KCNQ1 channel Cell. Physiol. Biochem. 29 2012 809 818
39. Z. Hosseinzadeh, S.K. Bhavsar, and F. Lang Downregulation of ClC-2 by JAK2 Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol., Biochem., Pharmacol. 29 2012 737 742
40. C. Munoz, M. Sopjani, M. Dermaku-Sopjani, A. Almilaji, M. Foller, and F. Lang Downregulation of the osmolyte transporters SMIT and BGT1 by AMP-Activated protein kinase Biochem. Biophys. Res. Commun. 422 2012 358 362
41. A. Almilaji, C. Munoz, Z. Hosseinzadeh, and F. Lang Upregulation of Na+, Cl(-)-coupled betaine/gamma-Amino-butyric acid transporter BGT1 by Tau tubulin kinase 2 Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol., Biochem., Pharmacol. 32 2013 334 343
42. A. Almilaji, T. Pakladok, A. Guo, C. Munoz, M. Foller, and F. Lang Regulation of the glutamate transporter EAAT3 by mammalian target of rapamycin mTOR Biochem. Biophys. Res. Commun. 421 2012 159 163
43. Z. Hosseinzadeh, S.K. Bhavsar, and F. Lang Down-regulation of the myoinositol transporter SMIT by JAK2 Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol., Biochem., Pharmacol. 30 2012 1473 1480
44. S. Mia, C. Munoz, T. Pakladok, G. Siraskar, J. Voelkl, I. Alesutan, and F. Lang Downregulation of Kv1.5 K channels by the AMP-Activated protein kinase Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol., Biochem., Pharmacol. 30 2012 1039 1050
45. G. Pathare, M. Foller, A. Daryadel, K. Mutig, E. Bogatikov, A. Fajol, A. Almilaji, D. Michael, G. Stange, J. Voelkl, C.A. Wagner, S. Bachmann, and F. Lang OSR1-sensitive renal tubular phosphate reabsorption Kidney Blood Press. Res. 36 2012 149 161
46. Z. Hosseinzadeh, M. Shojaiefard, S.K. Bhavsar, and F. Lang Up-regulation of the betaine/GABA transporter BGT1 by JAK2 Biochem. Biophys. Res. Commun. 420 2012 172 177
47. F. Lang, G.L. Busch, M. Ritter, H. Volkl, S. Waldegger, E. Gulbins, and D. Haussinger Functional significance of cell volume regulatory mechanisms Physiol. Rev. 78 1998 247 306
48. F. Lang Mechanisms and significance of cell volume regulation J. Am. Coll. Nutr. 26 2007 613S 623S